Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia

Bahrain Medical Bulletin

Volumn 28, Issue 4, 2006, Pages 164-167

  Al Jaouni, Soad K ^a   Al Muhayawi, Saad M ^a   Qari, Mohammad H ^a   Nawas, Mohammad Abu ^b   Al Mazrooa, Adnan ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOIDECTOMY; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHOLECYSTECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; HYDRATION; INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROLOGICAL COMPLICATION; OXYGENATION; PAIN; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; SAFETY; SICKLE CELL ANEMIA; SPLENECTOMY; SURGICAL TECHNIQUE; TONSILLECTOMY; TOTAL HIP PROSTHESIS;

EID: 33845529963     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Davies SC, Roberts-Harewood M. Blood transfusion in sickle cell disease. Blood Rev 1997; 11(2): 57-71.
2. Reed WF, Vichinsky EP. Transfusion practice for patients with sickle cell disease. Curr Opin Hematol 1999; 6(6): 432-436.
3. Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 1995; 86(10): 3676-84.
4. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999; 340(13): 1021-30.
5. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333(4): 206-13.
6. Haberkern CM, Neumayr LD, Orringer EP. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood 1997; 89: 1533-42.
7. Oduro KA, Searle JF. Anaesthesia in sickle-cell states: a plea for simplicity. Br Med J 1972; 4(840): 596-8.
8. Friedman DF, Kim HC, Manno CS. Hyperhemolysis associated with red cell transfusion in SCD. Transfusion 1993; 33: 14.
9. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93(3): 707-13.
10. Buchanan GR, Rogers ZR. Conservative versus aggressive transfusion regimens in sickle cell disease. N Engl J Med 1995; 333(24): 1641; author reply 1641-2.
11. Bischoff RJ, Williamson A 3rd, Dalali MJ, et al. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies. Ann Surg 1988; 207(4): 434-8.
12. Serjeant GR. Sickle cell disease. Oxford Med Pub 1992; 34: 455-9.
13. Serjeant GR, Serjeant BE. Management of sickle cell disease; lessons from the Jamaican Cohort Study. Blood Rev. 1993; 7(3): 137-45.
14. Serjeant GR. Chronic transfusion programmes in sickle cell disease: problem or panacea? Br J Haematol 1997; 97(2): 253-5.
15. Homi J, Reynolds J, Skinner A, et al. General anaesthesia in sickle-cell disease. Br Med J 1979; 1(6178): 1599-601.
16. Griffin TC, Buchanan GR. Elective surgery in children with sickle cell disease without preoperative blood transfusion. J Pediatr Surg 1993; 28(5): 681-5.
17. Robert-Harewood M, Hokes TJC, Taylor PC, et al. Adenotonsillectomy in sickle-cell-disease. Is routine transfusion necessary? Br J Haematol 1997; 97(suppli): 75.
18. Al Jaouni Sk, Qari MH, Damanhouri GA, et al. Chromatography phenotypes distribution of neonatal thalassemia and sickle cell anemia in hospitals births in Jeddah, Saudi Arabia. Egypt J Pediatr 2003; 20(3&4): 595-605.
19. Acquaye JK, Omer A, Ganeshaguru K, et al. Non-benign sickle cell anemia in western Saudi Arabia. Br J Haematol 1985; 60(1): 99-108.
20. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988; 260(18): 2700-3.
21. Practice strategies for elective red blood cell transfusion. American College of Physicians. Ann Intern Med 1992; 116(5): 403-6.
22. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84(3): 732-47.
23. Keidan AJ, Marwah SS, Vaughan GR, et al. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions. J Clin Pathol 1987; 40(5): 505-7.
24. Rackoff WR, Ohene-Frempong K, Month S, et al. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 1992; 120(6): 882-5.
25. Royal JE, Seeler RA. Hypertension, convulsions, and cerebral haemorrhage in sickle-cell anaemia patients after blood-transfusions. Lancet 1978; 2(8101): 1207-8.
26. Jan K, Usami S, Smith JA. Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion 1982; 22(1): 17-20.
27. Schmalzer EA, Lee JO, Brown AK, et al. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion. Transfusion 1987; 27(3): 228-33.
28. Al Muhayawi SM, Al Jaouni SK. Adenotonsillectomy in children with sickle cell anemia without preoperative blood transfusion. Saudi J Otorhinolaryngol Head Neck Surg 2005; 7(2): 68-71.
29. Al Jaouni SK, AlMuhayawi SM, Qari MH. The Safety of Avoiding Preoperative Transfusion in Patients with SCA. Haematologica 2006; 91 supplement(1): 414.